Benefits of omalizumab on anxiety and depression in patients with severe asthma
Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Babol University of Medical Sciences
2018-05-01
|
Series: | Caspian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://caspjim.com/browse.php?a_code=A-10-881-2&slc_lang=en&sid=1 |